drugset / Trial / NCT00175747

A Phase IIb Trial of Pulmicort Turbuhaler (Budesonide)

NCT00175747

RandomizedParallel-groupDouble-blindPrevention

Summary

Studies in animals suggest that inhaled budesonide may prevent the occurrence of lung cancer. We conducted a clinical trial to determine the effects of inhaled budesonide in smokers who had precancerous lesions in the breathing tubes (i.e. bronchial dysplasia.

Timeline

Start
2000-01
Primary completion
Completion
2002-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Budesonide Small molecule 800 ug Inhaled

Indications